TY - JOUR
T1 - Redox proteomics studies of in vivo amyloid beta-peptide animal models of Alzheimer's disease
T2 - Insight into the role of oxidative stress
AU - Sultana, Rukhsana
AU - Butterfield, D. Allan
PY - 2008/5
Y1 - 2008/5
N2 - Alzheimer's disease (AD) is an age-related neurodegenerative disease. AD is characterized by the presence of senile plaques, neurofibrillary tangles, and synaptic loss. Amyloid β-peptide (Aβ), a component of senile plaques, has been proposed to play an important role in oxidative stress in AD brain and could be one of the key factors in the pathogenesis of AD. In the present review, we discuss some of the AD animal models that express Aβ, and compare the proteomics-identified oxidatively modified proteins between AD brain and those of Aβ models. Such a comparison would allow better understanding of the role of Aβ in AD pathogenesis thereby helping in developing potential therapeutics to treat or delay AD.
AB - Alzheimer's disease (AD) is an age-related neurodegenerative disease. AD is characterized by the presence of senile plaques, neurofibrillary tangles, and synaptic loss. Amyloid β-peptide (Aβ), a component of senile plaques, has been proposed to play an important role in oxidative stress in AD brain and could be one of the key factors in the pathogenesis of AD. In the present review, we discuss some of the AD animal models that express Aβ, and compare the proteomics-identified oxidatively modified proteins between AD brain and those of Aβ models. Such a comparison would allow better understanding of the role of Aβ in AD pathogenesis thereby helping in developing potential therapeutics to treat or delay AD.
KW - Alzheimer's disease
KW - AmyIoid beta-peptide
KW - Caenorhabditis elegans
KW - Canine
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=44649144568&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44649144568&partnerID=8YFLogxK
U2 - 10.1002/prca.200780024
DO - 10.1002/prca.200780024
M3 - Review article
C2 - 21136866
AN - SCOPUS:44649144568
SN - 1862-8346
VL - 2
SP - 685
EP - 696
JO - Proteomics - Clinical Applications
JF - Proteomics - Clinical Applications
IS - 5
ER -